Ecnoglutide
XW003
A long-acting cAMP-biased GLP-1 analog studied in trials for weight management and type 2 diabetes. Not approved in the United States.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Investigational; no approved label defines handling.
References
- PubChem compound record
- Mol Metab 2023: discovery and characterisation of ecnoglutide
Read the source
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.